StepStone FRE Grew 30%. The Rest of the Report Told a Different Story.

The competitor headlines are already out: StepStone Group posted robust fee-related earnings in Q1 FY2027. FRE grew 30%. Management fees expanded. AUM is $245 billion. If your entire reading of the report stops there, you're missing the three numbers that explain why the stock fell 7.8% on the day and sits 27.7% below its 52-week high.

No stock means anything in isolation. Every judgment is relative to a sector comparison, and StepStone's sector is the alternatives managers — Blackstone, Carlyle, Apollo, KKR — that trade at positive earnings multiples, not negative ones. The factor stack on StepStone right now is a split record. Growth is strong. Profitability is a mess. Valuation has already collapsed to reflect the disconnect.

Valuation: C. The multiple tells you the market already knew.

StepStone trades at 2.8 times trailing sales, well below Carlyle Group's 4.7x. The price-to-book is 6.3x versus Carlyle's 2.3x, which means the market is paying less revenue multiple but more equity premium — a sign that the growth story has some credibility but the capital structure worries people. The trailing P/E is negative (-10.5x). So is the forward P/E (-36.4x). For a company in portfolio management, negative earnings multiples are a red flag unless the recovery path is clear and near.

Compared to the alternatives franchise model — where Blackstone trades at roughly 12x forward earnings and Carlyle at 46x trailing — StepStone's valuation has been stripped down hard. That's not a buying signal on its own. It's the market's way of saying the GAAP losses and equity compensation spike are real and not just accounting noise. The PEG ratio of 0.06 is technically stunning, but a PEG that low on a loss-making company is a mechanical artifact, not a green light.

Growth: A-. Revenue and AUM are the strong half of the report.

Revenue growth of 70% year-over-year is real. Fee revenues of $270.9 million grew 27%, with management fees up 30% as Fee-Earning AUM (FEAUM — the portion of AUM that actually generates management fees, excluding non-fee assets) reached $153.6 billion, up 21% year-over-year. Focused commingled funds pulled in $8.2 billion in new commitments, a 306% surge. That is not a vanity number. That's book-of-business momentum.

But total GAAP revenues grew only 4%, to $378.9 million. The difference between 27% fee revenue growth and 4% total revenue growth is performance fees — carried interest and incentive income — which fell 28% to $109.7 million. Performance fees are lumpy by nature, but a 28% drop in the same quarter that management fees are surging tells you the fee revenue growth is structural while the total revenue picture is still dependent on fund exits and mark-to-market gains that didn't materialize this quarter.

In our book, the A- on growth reflects fee revenue durability, not headline revenue quality. The underlying fee engine is accelerating. The realized profit engine is not.

Profitability: D. Equity compensation ate the quarter.

Here's the number the "robust FRE" headlines skip: adjusted net income fell 24% year-over-year to $60.3 million. ANI per share of $0.48 missed the consensus estimate of $0.53. The miss was driven by equity-based compensation of $317.3 million — up from $188.7 million a year ago. That's a $128.6 million increase in non-cash compensation in a single quarter.

FRE looks great at $105.6 million because FRE adjusts for a different slice of equity compensation than ANI does. FRE margin expanded to 39% from 38%. But the operating margin is negative 51.3%. The EBITDA margin is negative 49.0%. ROIC is negative 42.4%. These are not temporary accounting quirks. They are the fundamental profitability picture of a company that is spending more on equity awards than it generates in operating income.

GAAP net loss widened from $(12.0) million to $(170.4) million. That's a 14-fold deterioration. The question isn't whether FRE was robust. The question is whether equity compensation of $317 million in a quarter is a one-time structural charge or the new baseline. If it's the baseline, StepStone's profitability factor doesn't improve until revenue growth vastly outpaces comp growth — and that's a heavy lift.

Safety: B-. Net cash, but leverage is elevated.

The balance sheet isn't a crisis, but it's not clean either. Cash and equivalents sit at $1.1 billion against total debt of $5.9 billion. Net debt comes out negative — the company holds more cash than debt — but the debt-to-equity ratio is 135.6%. That's high for a lightly capitalized asset manager. Free cash flow of $64 million over the trailing twelve months is positive but thin against a $5.6 billion market cap. The dividend yield is 3.5%, which is attractive in isolation but the payout ratio is negative because GAAP earnings are negative. The dividend is funded from cash flows, not GAAP income, and that works only if FCF stays positive and growing.

Momentum: C. Neutral oscillators, downtrend intact.

RS-14 sits at 53.9 — dead center. The MACD line is slightly positive at 1.11, suggesting marginal upward pressure. But the stock is below its 200-day moving average of $54.6 and above its 50-day at $44.2, which means the long-term trend is still down and the short-term bounce hasn't established a floor. The 120-day change is negative 18.2%. Year-to-date it's negative 27.7%. A stock that's fallen nearly a third this year isn't getting a momentum upgrade on a single earnings beat.

What the factor stack actually says

AInvest's aggregate signal labels StepStone a Buy, with a fundamental rating of 4.49. That signal makes sense if you weight the AUM growth, fee revenue acceleration, and FEAUM momentum heavily — which is fair, because those are the durable inputs. But the composite analysis rating of 3.21 is lukewarm, and it captures the profitability and earnings reality that the FRE headline obscures.

The real question for investors is portfolio role. StepStone is a growth sleeve candidate, not a value play or an income hold. The fee engine is accelerating, FEAUM is $153.6 billion and growing, and new capital commitments nearly doubled year-over-year. If you believe the private markets cycle is still in its build phase and that the equity compensation spike is a one-off structural charge from the Greenspring integration, the current valuation at 2.8x sales is a discount to the franchise trajectory.

But if that $317 million in equity compensation is the new normal — and there's no evidence yet that it isn't — then the negative operating margins and the widening GAAP losses are the real story, not the FRE growth. In that case, StepStone belongs on the watchlist, not the buy list, until profitability turns positive on a GAAP basis and the equity comp trajectory flattens.

Hold until the next earnings report clarifies which quarter this was. A move from D to C+ on profitability would be the trigger. Another spike in equity comp and a repeat ANI miss would confirm the bear case. The barbell answer while you wait: pair exposure to fee-growth asset managers with names that are already profitable and yielding, so the portfolio doesn't hinge on one non-GAAP metric telling the whole story.